Literature DB >> 22249247

Mutations and deletions of ARID1A in breast tumors.

S Cornen, J Adelaide, F Bertucci, P Finetti, A Guille, D J Birnbaum, D Birnbaum, M Chaffanet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22249247     DOI： 10.1038/onc.2011.598

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


× No keyword cloud information.
  32 in total

1.  Genomic and proteomic characterization of ARID1A chromatin remodeller in ampullary tumors.

Authors:  Anca Nastase; Jin Yao Teo; Hong Lee Heng; Cedric Chuan Young Ng; Swe Swe Myint; Vikneswari Rajasegaran; Jia Liang Loh; Ser Yee Lee; London Lucien Ooi; Alexander Yaw Fui Chung; Pierce Kah Hoe Chow; Peng Chung Cheow; Wei Keat Wan; Rafy Azhar; Avery Khoo; Sam Xin Xiu; Syed Muhammad Fahmy Alkaff; Ioana Cutcutache; Jing Quan Lim; Choon Kiat Ong; Vlad Herlea; Simona Dima; Dan G Duda; Bin Tean Teh; Irinel Popescu; Tony Kiat Hon Lim
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  ARID1A is downregulated in non-small cell lung cancer and regulates cell proliferation and apoptosis.

Authors:  Yi Zhang; Xiaoman Xu; Meng Zhang; Xue Bai; Hui Li; Liang Kan; Huiyan Niu; Ping He
Journal:  Tumour Biol       Date:  2014-02-26

Review 3.  SWI/SNF chromatin remodeling complexes and cancer.

Authors:  Jaclyn A Biegel; Tracy M Busse; Bernard E Weissman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-08-28       Impact factor: 3.908

Review 4.  Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Authors:  A R M Ruhul Amin; Phillip A Karpowicz; Thomas E Carey; Jack Arbiser; Rita Nahta; Zhuo G Chen; Jin-Tang Dong; Omer Kucuk; Gazala N Khan; Gloria S Huang; Shijun Mi; Ho-Young Lee; Joerg Reichrath; Kanya Honoki; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; W Nicol Keith; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Hiromasa Fujii; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang; Alan Bilsland; Dong M Shin
Journal:  Semin Cancer Biol       Date:  2015-03-06       Impact factor: 15.707

Review 5.  The emerging roles of ARID1A in tumor suppression.

Authors:  Ren-Chin Wu; Tian-Li Wang; Ie-Ming Shih
Journal:  Cancer Biol Ther       Date:  2014-03-11       Impact factor: 4.742

6.  ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancer.

Authors:  Xiao Guo; Yin Zhang; Anand Mayakonda; Vikas Madan; Ling-Wen Ding; Le-Hang Lin; Saadiya Zia; Sigal Gery; Jeffrey W Tyner; Wu Zhou; Dong Yin; De-Chen Lin; H Phillip Koeffler
Journal:  Oncogene       Date:  2018-07-06       Impact factor: 9.867

7.  ARID1A: a potential prognostic factor for breast cancer.

Authors:  Jing Zhao; Caigang Liu; Zuowei Zhao
Journal:  Tumour Biol       Date:  2014-01-16

8.  Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus.

Authors:  M M Streppel; S Lata; M DelaBastide; E A Montgomery; J S Wang; M I Canto; A M Macgregor-Das; S Pai; F H M Morsink; G J Offerhaus; E Antoniou; A Maitra; W R McCombie
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

Review 9.  ARID1A mutations in cancer: another epigenetic tumor suppressor?

Authors:  Jennifer N Wu; Charles W M Roberts
Journal:  Cancer Discov       Date:  2012-12-03       Impact factor: 39.397

Review 10.  Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer.

Authors:  Christoph Plass; Stefan M Pfister; Anders M Lindroth; Olga Bogatyrova; Rainer Claus; Peter Lichter
Journal:  Nat Rev Genet       Date:  2013-10-09       Impact factor: 53.242
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.